Methacholine (iodide)
CAT:
804-HY-A0083C
Size:
1 Each
For Laboratory Research Only. Not for Clinical or Personal Use.
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Methacholine (iodide)
Description:
Methacholine iodide is a potent muscarinic-3 (M3) agonist. Methacholine iodide acts directly on acetylcholine receptors on smooth muscle causing bronchoconstriction and airway narrowing. Methacholine iodide shows a high sensitivity to identify bronchial hyperresponsiveness (BHR) . Methacholine iodide can be used to measure airway hyperresponsiveness (AHR) as a diagnostic aid in the assessment of individuals with asthma-like symptoms and normal resting expiratory flow rates[1][2][3][4].Product Name Alternative:
Acetyl-β-methylcholine (iodide)UNSPSC:
12352211Target:
MAChRType:
Reference compoundRelated Pathways:
GPCR/G Protein; Neuronal SignalingField of Research:
Cardiovascular DiseaseAssay Protocol:
https://www.medchemexpress.com/methacholine-iodide.htmlSmiles:
O=C(C)OC(C[N+](C)(C)C)C.[I-]Molecular Formula:
C8H18INO2Molecular Weight:
287.14References & Citations:
[1]Cohen J, et al. Relationship between airway responsiveness to neurokinin A and methacholine in asthma. Pulm Pharmacol Ther. 2005;18 (3) :171-176.|[2]Anderson SD, et al. Comparison of mannitol and methacholine to predict exercise-induced bronchoconstriction and a clinical diagnosis of asthma. Respir Res. 2009;10 (1) :4. Published 2009 Jan 23.|[3]Cockcroft DW. Methacholine challenge methods. Chest. 2008;134 (4) :678-680.|[4]Kabara S, et al. Differential effects of thiopental on methacholine- and serotonin-induced bronchoconstriction in dogs. Br J Anaesth. 2003 Sep;91 (3) :379-84.|[5]Folkerts G, et al. Bradykinin causes inhibition of methacholine-induced bronchoconstriction in vivo in mice. Naunyn Schmiedebergs Arch Pharmacol. 2001 Jul;364 (1) :53-8.|[6]Vitorasso RL, et al. Methacholine dose response curve and acceptability criteria of respiratory mechanics modeling. Exp Lung Res. 2020 Feb-Mar;46 (1-2) :23-31.Shipping Conditions:
Room temperatureScientific Category:
Reference compound1Clinical Information:
Phase 4CAS Number:
625-19-4
